Results for atherothrombotic translation from Finnish to English

haittavaikutuksia arvioitiin 19 632:lla zontivity-hoitoa saaneella potilaalla [13 186 potilaalla, joista 2187 sai hoitoa yli kolmen vuoden ajan, tra 2°p - timi 50 -tutkimuksessa (thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events) ja 6446 potilaalla tracer-tutkimuksessa (thrombin receptor antagonist for clinical event reduction in acute coronary syndrome)].
adverse reactions were evaluated in 19,632 patients treated with zontivity [13,186 patients, including 2,187 patients treated for more than 3 years, in the tra 2°p timi 50 (thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events) study and 6,446 patients in the tracer (thrombin receptor antagonist for clinical event reduction in acute coronary syndrome) study].